CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 8-K Event Material agreement · Regulation FD disclosure
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Regulation FD disclosure
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 4 Option exercise Director acquired 1,200 shares (option exercise)
- 4 Open-market sale Director sold 5,182 shares at an average $5.40 ($28,004)
- 4 Open-market sale Director sold 446,378 shares at an average $5.30 ($2,364,521)
- 4 Open-market sale President, CEO and Director sold 446,378 shares at an average $5.30 ($2,364,521)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market buy President, CEO and Director bought 1,222 shares at $6.55 ($7,998)
- 4 Open-market buy Director bought 1,222 shares at $6.55 ($7,998)
Page 8 of 26 · 506 filings